Fertility warning
This medicine may affect fertility.
Leaflet INFERGEN 9mcg / 0.3ml solution for injection
- Product code:
- W07581002
- Quantity:
- 6
- Indicated for:
- viral infections; multiple sclerosis; cancer
- Route of administration:
- injectable
- Substance:
- interferon alfacon-1 (antineoplastic agent)
- ATC
- L03AB09 — Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Interferon alfacon-1 is a medication used for the treatment of chronic hepatitis C. It is a recombinant form of interferon alfa that works by stimulating the immune response and inhibiting viral replication.
The medication is administered as a subcutaneous injection, as directed by a doctor, usually several times a week. It is important for patients to follow the treatment regimen and undergo regular check-ups.
Patients should be aware of potential side effects, such as flu-like symptoms, fatigue, or depression. It is important to inform the doctor of any unusual symptoms.
Common side effects include flu-like symptoms, fatigue, and depression. In rare cases, severe reactions such as liver impairment or hematologic disorders may occur. Patients should be informed of these risks before starting treatment.
The medication is administered as a subcutaneous injection, as directed by a doctor, usually several times a week. It is important for patients to follow the treatment regimen and undergo regular check-ups.
Patients should be aware of potential side effects, such as flu-like symptoms, fatigue, or depression. It is important to inform the doctor of any unusual symptoms.
Common side effects include flu-like symptoms, fatigue, and depression. In rare cases, severe reactions such as liver impairment or hematologic disorders may occur. Patients should be informed of these risks before starting treatment.
General data about INFERGEN 9mcg / 0.3ml
- Substance:
- interferon alfacon-1
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W07581002
- Concentration:
- 9mcg / 0.3ml
- Pharmaceutical form:
- solution for injection
- Quantity:
- 6
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.